Back to investors
ACORN CAPITAL ADVISORS, LLC
ACORN CAPITAL ADVISORS, LLC
Latest filing: 2026-06-30
ACORN CAPITAL ADVISORS, LLC runs ACORN CAPITAL ADVISORS, LLC and currently holds 20 stock positions, which is fewer than the average of 230 among the investors we track. The portfolio is valued at approximately $366.46M. Their top holdings are CGON, TRVI, JBIO, BCAX, TARA. The top five represent 45.9% of reported portfolio weight. ACORN CAPITAL ADVISORS, LLC ranks #125 out of 1000 investors tracked by Alpha Score. They added to 3 existing positions. They trimmed 1 position. Their current best-performing preview position is JBIO with returns of +58.15%.
Sign in to enable email alerts for this investor.
Showper page
20 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 CGON CG ONCOLOGY INC | 21.94% | $28.72 | $79.81 | +177.89% | Added +0.09% |
 TRVI TREVI THERAPEUTICS INC | 10.92% | $4.27 | $17.96 | +320.61% | Held |
 JBIO JADE BIOSCEINCES INC | 5.98% | $15.71 | $21.34 | +35.84% | Added +25.42% |
 BCAX BICARA THERAPEUTICS | 5.21% | $17.42 | $23.90 | +37.20% | Trimmed -0.00% |
 TARA PROTARA THERAPEUTICS INC | 1.83% | $4.67 | $3.85 | -17.56% | Held |
 AURA AURA BIOSCIENCES INC | 1.80% | $6.31 | $7.80 | +23.61% | Added +55.95% |
 VSTM VERASTEM INC | 1.53% | $6.37 | $6.89 | +8.16% | Held |
Showing 1-10 of 20